Level Four Advisory Services LLC decreased its position in Balchem Co. (NASDAQ:BCPC – Free Report) by 8.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,104 shares of the basic materials company’s stock after selling 531 shares during the quarter. Level Four Advisory Services LLC’s holdings in Balchem were worth $995,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Arizona State Retirement System raised its position in Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company’s stock worth $1,534,000 after acquiring an additional 77 shares in the last quarter. Heritage Family Offices LLP grew its stake in shares of Balchem by 8.3% in the 4th quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company’s stock worth $231,000 after purchasing an additional 109 shares during the last quarter. Inspire Investing LLC raised its holdings in shares of Balchem by 4.9% in the 4th quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company’s stock worth $401,000 after purchasing an additional 114 shares in the last quarter. Westside Investment Management Inc. acquired a new stake in Balchem during the third quarter valued at approximately $27,000. Finally, Inspire Advisors LLC boosted its holdings in Balchem by 3.2% during the fourth quarter. Inspire Advisors LLC now owns 5,123 shares of the basic materials company’s stock worth $835,000 after buying an additional 161 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.
Balchem Stock Down 1.4 %
Shares of NASDAQ:BCPC opened at $163.79 on Monday. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The company has a market cap of $5.33 billion, a PE ratio of 41.68, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The firm has a 50 day simple moving average of $165.26 and a 200 day simple moving average of $169.28.
Wall Street Analyst Weigh In
Several research firms have issued reports on BCPC. HC Wainwright reaffirmed a “buy” rating and issued a $190.00 price target on shares of Balchem in a report on Monday, February 24th. Sidoti raised Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th.
View Our Latest Stock Analysis on BCPC
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Best Stocks Under $10.00
- MarketBeat Week in Review – 03/24 – 03/28
- Comparing and Trading High PE Ratio Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.